Skip to main content

Table 1 Clinical characteristics of the patients and a control group

From: Th17 responses are not altered by natural exposure to seasonal allergens in pollen-sensitive patients

Patient characteristics

Experimental group

Control group

Age

31.8 ± 12.1

31.2 ± 5.3

Sex

M:9; F:7

M:9; F:7

Disease

Allergic rhinitis

15

(93.8 %)

0

Asthma

10

(62.5 %)

0

Allergic conjunctivitis

14

(87.5 %)

0

Atopic dermatitis

1

(6.25 %)

0

Skin prick test positivity

Alder

13

(81.3 %)

0

Hazel

13

(81.3 %)

0

Birch

12

(75.0 %)

0

Grass

11

(68.8 %)

0

Specific IgE level for skin prick testpositive patients [IU/l]

Alder

15.3 ± 19.7

 

N.A.

Hazel

5.5 ± 7.5

 

N.A.

Birch

56.0 ± 39.2

 

N.A.

Grass

43.1 ± 46.4

 

N.A.

Specific IgE level for dominant allergen [IU/l]

41.0 ± 43.7

 

N.A.

Currently smoking

2

(12.5 %)

1

(6.25 %)

Treatment

Inhaled steroid

7

(43.8 %)

0

Short acting β2-mimetic

2

(12.5 %)

0

Montelukast

2

(12.5 %)

0

Long acting β2-mimetic

1

(6.25 %)

0

  1. Age and specific IgE levels are shown as mean ± SD, other features as number of patients
  2. Comorbidity of seasonal allergic rhinitis and asthma was observed in 9 individuals
  3. Coexistence of allergy for tree and grass pollen was observed in 9 patients